Mohamed El Fakiri

Name	Mohamed El Fakiri
Education/Training	BSc. in Chemistry - University of Barcelona MSc. in Medicinal Chemistry - University of Copenhagen
Start of PhD Thesis and Group	03/2021, Prof. Matthias Eder
Subject of Thesis	Design, synthesis and preclinical evaluation of cancer-targeting radiopharmaceuticals
Research Interests	Radiopharmaceuticals, Molecular Imaging, Targeted Radionuclide Therapy, alpha-emitters, tumour microenviroment, cancer-specific receptors, novel tumour biomarkers.
Methods and Techniques	Radiochemistry, Organic Synthesis, Peptide Synthesis, Chromatographic techniques, Animal Experiments, Cell culture, Cell assays, Scientific writing, PMOD imaging software.
Publications	Gandioso, A.; El Fakiri, M.; Rovira, A.; Marchan, V. RSC Adv., 2020, 10, 29829 https://doi.org/10.1039/D0RA06322C El Fakiri, M.; Geis, N.M.; Ayada, N.; Eder, M.; Eder, A.-C. Cancers 2021, 13, 3967. https://doi.org/10.3390/cancers13163967 El Fakiri M, Ayada N, Müller M, Hvass L, Gamzov TH, Clausen AS, Geis NM, Steinacker N, Hansson E, Lindegren S, Aneheim E, Jensen H, Eder AC, Jensen AI, Poulie CBM, Kjaer A, Eder M, Herth MM. Development and Preclinical Evaluation of [²¹¹At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer. J Nucl Med. 2024 Apr 1;65(4):593-599. doi: 10.2967/jnumed.123.267043.
Contact	mohamed.el.fakiri[at]uniklinik-freiburg.de